Detection of Parental Contribution to Molar Genome Leads to Diagnosis of Recurrent Hydatidiform Mole in a Family with NLRP7 Variants

Fetal Pediatr Pathol. 2022 Jun;41(3):511-515. doi: 10.1080/15513815.2020.1852463. Epub 2020 Nov 30.

Abstract

Introduction: Genetically, complete hydatidiform mole (CHM) is androgenetic diploid, containing two sets of paternal chromosomes. In most cases, recurrent HM (RHM) is CHM but has diploid biparental chromosome constitution. Case report: We report a mother with RHM, both with biparental diploidy. The mother was compound heterozygous for two variants, c.1720dup, p.(C574Lfs*4) and c.2165A > G, p.(D722G) of the NLRP7 gene, as was a brother who fathered 2 normal pregnancies. Conclusion: The genotype study should be obtained for patients of CHM, even in their first pregnancy, followed by genetic screening for maternal-effect variants in those with biparental moles. This strategy will identify patients in their first pregnancy with HM that have a decreased chance for a normal pregnancy, to allow genetic counseling, perhaps utilizing a donor egg.

Keywords: Hydatidiform mole; NLRP7; parentage; recurrent molar pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Female
  • Gestational Trophoblastic Disease*
  • Humans
  • Hydatidiform Mole* / diagnosis
  • Hydatidiform Mole* / genetics
  • Male
  • Neoplasm Recurrence, Local
  • Parents
  • Pregnancy
  • Uterine Neoplasms* / diagnosis
  • Uterine Neoplasms* / genetics

Substances

  • Adaptor Proteins, Signal Transducing
  • NLRP7 protein, human